Search research articles
Contact Us
Filters
Showing results (341-350 of 773) with videos related to
Page
of 78
Sort By:
American Journal of Nephrology
|
April 5, 2012
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation
Harris V K Naina, Samar Harris, Angela Dispenzieri, et al.
Cancer
|
October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma
Shaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal
|
February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
David L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
Blood Cancer Journal
|
July 26, 2022
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Marie-France Gagnon, Shulan Tian, Susan Geyer, et al.
Blood
|
September 19, 2008
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
Michael Wang, Meletios A Dimopoulos, Christine Chen, et al.
Blood
|
June 3, 2006
Immunoglobulin free light chains and solitary plasmacytoma of bone
David Dingli, Robert A Kyle, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
S Vincent Rajkumar, Suzanne Hayman, Morie A Gertz, et al.
Blood
|
November 2, 2011
Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS
Alvin C Ng, Sundeep Khosla, Natthinee Charatcharoenwitthaya, et al.
Blood Cancer Journal
|
April 20, 2022
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
Geffen Kleinstern, Dirk R Larson, Cristine Allmer, et al.
Mayo Clinic Proceedings
|
August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition
Terry M Therneau, Robert A Kyle, L Joseph Melton, et al.
Page
of 78
Search research articles
Search
Showing results (341-350 of 773) with videos related to
Sort By:
Page
of 78
American Journal of Nephrology
|
April 5, 2012
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation
Harris V K Naina, Samar Harris, Angela Dispenzieri, et al.
Cancer
|
October 20, 2011
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma
Shaji K Kumar, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal
|
February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
David L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
Blood Cancer Journal
|
July 26, 2022
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Marie-France Gagnon, Shulan Tian, Susan Geyer, et al.
Blood
|
September 19, 2008
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
Michael Wang, Meletios A Dimopoulos, Christine Chen, et al.
Blood
|
June 3, 2006
Immunoglobulin free light chains and solitary plasmacytoma of bone
David Dingli, Robert A Kyle, S Vincent Rajkumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
S Vincent Rajkumar, Suzanne Hayman, Morie A Gertz, et al.
Blood
|
November 2, 2011
Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS
Alvin C Ng, Sundeep Khosla, Natthinee Charatcharoenwitthaya, et al.
Blood Cancer Journal
|
April 20, 2022
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
Geffen Kleinstern, Dirk R Larson, Cristine Allmer, et al.
Mayo Clinic Proceedings
|
August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition
Terry M Therneau, Robert A Kyle, L Joseph Melton, et al.
Page
of 78